Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.80

-3.5%

Dec 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1814)	6/19/2007 3:46:22 PM
From: Jibacoa	Read Replies (2) of 3722

PARS Seems to have found support at the $1.30 level. bigcharts.marketwatch.com It has closed its Apr 24 UG. bigcharts.marketwatch.com April 24 was the day when it announced the results from its PIIa of the effects of i.v. cannabinor against post-operative pain in over 100 male patients undergoing third molar dental extraction. At the lowest dose of cannabinor (12 mgs), it produced a statistically significant decrease in pain vs placebo, but , this result wasn't seen in the higher dose groups (24mgs and 48mgs), & the company has no explanation for that pattern of results.<g> There were no significant side effects at any of the 3 different dose levels. PARS has no significant LTD. It trades around 1.5x BV. The R/R looks OK at present levels. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next